Network-based method to infer the contributions of proteins to the etiology of drug side effects
暂无分享,去创建一个
[1] Doheon Lee,et al. Building the process-drug–side effect network to discover the relationship between biological Processes and side effects , 2011, BMC Bioinformatics.
[2] L. Xiangjun,et al. ? Higher Education Press and Springer-Verlag 2007 , 2007 .
[3] Damian Szklarczyk,et al. STITCH 3: zooming in on protein–chemical interactions , 2011, Nucleic Acids Res..
[4] John D. Lafferty,et al. Diffusion Kernels on Graphs and Other Discrete Input Spaces , 2002, ICML.
[5] J. Chen,et al. Predicting adverse drug reaction profiles by integrating protein interaction networks with drug structures , 2013, Proteomics.
[6] Daniel C. Liebler,et al. Elucidating mechanisms of drug-induced toxicity , 2005, Nature Reviews Drug Discovery.
[7] R. Zatz,et al. Cyclooxygenase-2 (COX-2) inhibition limits abnormal COX-2 expression and progressive injury in the remnant kidney. , 2003, Kidney international.
[8] Bo Zhang,et al. Network target for screening synergistic drug combinations with application to traditional Chinese medicine , 2011, BMC Systems Biology.
[9] Chih-Jen Lin,et al. Simple Probabilistic Predictions for Support Vector Regression , 2004 .
[10] R. Sinniah,et al. Downregulation of Bcl-2 by podocytes is associated with progressive glomerular injury and clinical indices of poor renal prognosis in human IgA nephropathy. , 2004, Journal of the American Society of Nephrology : JASN.
[11] Jin Gu,et al. Imbalanced network biomarkers for traditional Chinese medicine Syndrome in gastritis patients , 2013, Scientific Reports.
[12] Shiwen Zhao,et al. Network-Based Relating Pharmacological and Genomic Spaces for Drug Target Identification , 2010, PloS one.
[13] Lan Fan,et al. Pharmacogenetics of drugs withdrawn from the market. , 2012, Pharmacogenomics.
[14] Allen D. Roses,et al. Pharmacogenetics and drug development: the path to safer and more effective drugs , 2004, Nature Reviews Genetics.
[15] Roded Sharan,et al. An Algorithmic Framework for Predicting Side-Effects of Drugs , 2010, RECOMB.
[16] R. Nowack,et al. Herbal treatments of glomerulonephritis and chronic renal failure: Review and recommendations for research , 2011 .
[17] Michael J. Keiser,et al. Large Scale Prediction and Testing of Drug Activity on Side-Effect Targets , 2012, Nature.
[18] M. Jadoul,et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs , 1993, The Lancet.
[19] Livia Perfetto,et al. MINT, the molecular interaction database: 2009 update , 2009, Nucleic Acids Res..
[20] Bo Zhang,et al. An Integrative Platform of TCM Network Pharmacology and Its Application on a Herbal Formula, Qing-Luo-Yin , 2013, Evidence-based complementary and alternative medicine : eCAM.
[21] Navdeep Jaitly,et al. A Structure-Based Approach for Mapping Adverse Drug Reactions to the Perturbation of Underlying Biological Pathways , 2010, PloS one.
[22] Bin Chen,et al. Gaining Insight into Off-Target Mediated Effects of Drug Candidates with a Comprehensive Systems Chemical Biology Analysis , 2009, J. Chem. Inf. Model..
[23] P. Bork,et al. Systematic identification of proteins that elicit drug side effects , 2013, Molecular systems biology.
[24] Rafael C. Jimenez,et al. The IntAct molecular interaction database in 2012 , 2011, Nucleic Acids Res..
[25] Gary D Bader,et al. BIND--The Biomolecular Interaction Network Database. , 2001, Nucleic acids research.
[26] Chih-Jen Lin,et al. LIBSVM: A library for support vector machines , 2011, TIST.
[27] A. Hishida,et al. Attenuation of cisplatin-induced acute renal failure is associated with less apoptotic cell death. , 1999, The Journal of laboratory and clinical medicine.
[28] Hanno Steen,et al. Development of human protein reference database as an initial platform for approaching systems biology in humans. , 2003, Genome research.
[29] T. Efferth,et al. Mechanisms of herb-induced nephrotoxicity. , 2013, Current medicinal chemistry.
[30] Yoshihiro Yamanishi,et al. Relating drug–protein interaction network with drug side effects , 2012, Bioinform..
[31] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[32] Shao Li,et al. A novel network pharmacology approach to analyse traditional herbal formulae: the Liu-Wei-Di-Huang pill as a case study. , 2014, Molecular bioSystems.
[33] Yoshihiro Yamanishi,et al. Drug Side-Effect Prediction Based on the Integration of Chemical and Biological Spaces , 2012, J. Chem. Inf. Model..
[34] R. Harris,et al. COX-2 and the Kidney , 2006, Journal of cardiovascular pharmacology.
[35] David S. Wishart,et al. DrugBank 3.0: a comprehensive resource for ‘Omics’ research on drugs , 2010, Nucleic Acids Res..
[36] P. Bork,et al. A side effect resource to capture phenotypic effects of drugs , 2010, Molecular systems biology.
[37] J. Chen,et al. Predicting adverse side effects of drugs , 2011, BMC Genomics.
[38] H. Liapis,et al. Expression of bcl-2 and bax in regenerating rat renal tubules following ischemic injury. , 1997, The American journal of physiology.
[39] Bo Zhang,et al. Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae , 2010, BMC Bioinform..
[40] Igor Jurisica,et al. Online Predicted Human Interaction Database , 2005, Bioinform..
[41] Seth I. Berger,et al. Role of systems pharmacology in understanding drug adverse events , 2011, Wiley interdisciplinary reviews. Systems biology and medicine.
[42] M. Milik,et al. Mapping adverse drug reactions in chemical space. , 2009, Journal of medicinal chemistry.
[43] L. Hunyady,et al. Identification of the invariant chain (CD74) as an angiotensin AGTR1-interacting protein. , 2008, The Journal of endocrinology.
[44] James L Stevens,et al. The future of drug safety testing: expanding the view and narrowing the focus. , 2009, Drug discovery today.
[45] R. Shah,et al. Can pharmacogenetics help rescue drugs withdrawn from the market? , 2006, Pharmacogenomics.